DNA Script attracts $38.5 mln Series B

Paris-based DNA Script, a maker of synthetic nucleic acids, has raised $38.5 million in Series B financing. The investors included LSP, BPIFrance, Kurma Partners, Idinvest Partners, Illumina Ventures and M Ventures.

Source: Press Release

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!